Boston Team Developing PLA2R Antibody Test for Membranous Nephropathy
December 16, 2011
Boston Team Developing PLA2R Antibody Test for Membranous Nephropathy
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Biodesix Publishes Study Indicating Significant Influence of Veristrat on Doctor Treatment Decisions
April 5, 2013 / ProteoMonitor - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News - UK Study Suggests VEGF Splice Isoform Ratio Could Predict Colorectal Cancer Patients' Avastin Response
November 2, 2012 / Pharmacogenomics Reporter - GMU Phosphoproteomic Studies Offer Potential Clinical Insights on Breast, Colorectal Cancers
October 12, 2012 / ProteoMonitor - Study Suggests Biodesix's Veristrat Can Identify NSCLC Responders to Erlotinib, Gemcitabine
September 7, 2012 / ProteoMonitor